435 results found
Download results as 
or XML
or XML
| Company | Parent | Location | Subsidy Source | Year |
Subsidy Value |
Loan/Bailout Value | Type of Subsidy |
|---|---|---|---|---|---|---|---|
| ACAMBIS INC | Sanofi | United States | federal | 2004 | $67,000,000 | federal grant | |
| Novozymes Blair, Inc. | Novo A/S | United States | federal | 2010 | $28,401,000 | federal allocated tax credit | |
| AMYRIS, INC. | Amyris | United States | federal | 2010 | $24,341,409 | federal grant | |
| XOMA (US) LLC | Xoma Corp. | United States | federal | 2005 | $15,000,000 | federal grant | |
| NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, | Novartis | United States | federal | 2017 | $12,060,156 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2000 | $11,094,599 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2004 | $10,427,728 | federal grant | |
| CELGENE CORPORATION | Celgene | United States | federal | 2010 | $10,061,240 | federal grant | |
| SHIRE BIOLOGICS INC | Takeda Pharmaceutical | United States | federal | 2004 | $9,500,092 | federal grant | |
| ACAMBIS INC | Sanofi | United States | federal | 2005 | $9,284,386 | federal grant | |
| ACAMBIS INC | Sanofi | United States | federal | 2003 | $9,241,818 | federal grant | |
| CHIMERIX INC | Chimerix | United States | federal | 2005 | $8,477,202 | federal grant | |
| CHIMERIX INC | Chimerix | United States | federal | 2004 | $7,492,027 | federal grant | |
| CELGENE CORPORATION | Celgene | United States | federal | 2012 | $7,489,743 | federal grant | |
| WYETH PHARMACEUTICALS INC | Pfizer | United States | federal | 2003 | $7,271,925 | federal grant | |
| AMYRIS, INC. | Amyris | United States | federal | 2016 | $7,000,000 | federal grant | |
| AMYRIS, INC. | Amyris | United States | federal | 2018 | $7,000,000 | federal grant | |
| AMYRIS, INC. | Amyris | United States | federal | 2019 | $7,000,000 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2005 | $6,884,362 | federal grant | |
| AMYRIS, INC. | Amyris | United States | federal | 2018 | $6,825,720 | federal grant | |
| WYETH PHARMACEUTICALS INC | Pfizer | United States | federal | 2005 | $6,364,931 | federal grant | |
| WYETH | Pfizer | United States | federal | 2005 | $5,636,276 | federal grant | |
| TAKEDA VACCINES, INC. | Takeda Pharmaceutical | United States | federal | 2018 | $5,385,144 | federal grant | |
| WYETH PHARMACEUTICALS INC | Pfizer | United States | federal | 2005 | $4,934,072 | federal grant | |
| AVENTIS PASTEUR, INC | Sanofi | United States | federal | 2004 | $4,923,670 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2002 | $4,920,585 | federal grant | |
| MEDIMMUNE, LLC | AstraZeneca | United States | federal | 2018 | $4,893,180 | federal grant | |
| MEDIMMUNE, LLC | AstraZeneca | United States | federal | 2017 | $4,864,964 | federal grant | |
| NOVOZYMES, INC | Novo A/S | United States | federal | 2008 | $4,694,082 | federal grant | |
| NOVOZYMES, INC | Novo A/S | United States | federal | 2008 | $4,694,082 | federal grant | |
| REGENERON PHARMACEUTICALS INC | Regeneron Pharmaceuticals | United States | federal | 2007 | $4,614,400 | federal grant | |
| NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, | Novartis | United States | federal | 2014 | $4,327,868 | federal grant | |
| ETHICON, INC | Johnson & Johnson | United States | federal | 2009 | $4,260,809 | federal grant | |
| GlaxoSmithKline | GlaxoSmithKline | United States | federal | 2012 | $4,011,709 | federal grant | |
| NOVARTIS VACCINES DIAGNOSTICS, | Novartis | United States | federal | 2012 | $3,864,927 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2002 | $3,840,693 | federal grant | |
| PFIZER INC. | Pfizer | United States | federal | 2014 | $3,823,709 | federal grant | |
| AMERICAN HOME PRODUCTS CORPORATION | Pfizer | United States | federal | 2000 | $3,773,578 | federal grant | |
| CELGENE CORPORATION | Celgene | United States | federal | 2011 | $3,687,247 | federal grant | |
| AMYRIS BIOTECHNOLOGIES, INC | Amyris | United States | federal | 2012 | $3,595,518 | federal grant | |
| AMERICAN HOME PRODUCTS CORPORATION | Pfizer | United States | federal | 2004 | $3,582,393 | federal grant | |
| PROGENICS PHARMACEUTICALS, INC | Progenics Pharmaceuticals | United States | federal | 2004 | $3,351,512 | federal grant | |
| NOVOZYMES, INC | Novo A/S | United States | federal | 2009 | $3,289,888 | federal grant | |
| AMERICAN HOME PRODUCTS CORPORATION | Pfizer | United States | federal | 2001 | $3,247,250 | federal grant | |
| CELGENE CORPORATION | Celgene | United States | federal | 2009 | $3,170,533 | federal grant | |
| AVENTIS PASTEUR, INC | Sanofi | United States | federal | 2003 | $3,121,883 | federal grant | |
| PROGENICS PHARMACEUTICALS, INC | Progenics Pharmaceuticals | United States | federal | 2003 | $3,054,013 | federal grant | |
| PROGENICS PHARMACEUTICALS, INC | Progenics Pharmaceuticals | United States | federal | 2005 | $3,000,072 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2003 | $2,984,358 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2003 | $2,984,358 | federal grant | |
| WYETH PHARMACEUTICALS INC | Pfizer | United States | federal | 2002 | $2,968,632 | federal grant | |
| PFIZER INC. | Pfizer | United States | federal | 2014 | $2,784,665 | federal grant | |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | United States | federal | 2012 | $2,713,491 | federal grant | |
| NOVARTIS VACCINES AND DIAGNOSTICS, INC | Novartis | United States | federal | 2014 | $2,713,057 | federal grant | |
| NOVAVAX, INC | Novavax Inc. | United States | federal | 2003 | $2,695,203 | federal grant | |
| GENOCEA BIOSCIENCES INC | Genocea Biosciences | United States | federal | 2009 | $2,685,993 | federal grant | |
| ACORDA THERAPEUTICS, INC | Acorda Therapeutics | United States | federal | 2013 | $2,675,008 | federal grant | |
| NOVOZYMES, INC. | Novo A/S | United States | federal | 2013 | $2,500,000 | federal grant | |
| NOVOZYMES, INC. | Novo A/S | United States | federal | 2018 | $2,500,000 | federal grant | |
| NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, | Novartis | United States | federal | 2015 | $2,473,302 | federal grant | |
| SANOFI PASTEUR VAXDESIGN CORPORATION | Sanofi | United States | federal | 2014 | $2,433,738 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2004 | $2,407,540 | federal grant | |
| MEDIMMUNE, LLC | AstraZeneca | United States | federal | 2018 | $2,383,754 | federal grant | |
| SANOFI US SERVICES INC. | Sanofi | United States | federal | 2018 | $2,382,409 | federal grant | |
| AVENTIS PASTEUR, INC | Sanofi | United States | federal | 2004 | $2,362,639 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2001 | $2,359,223 | federal grant | |
| STRATATECH CORPORATION | Mallinckrodt | United States | federal | 2016 | $2,357,660 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2003 | $2,306,242 | federal grant | |
| MORPHOTEK INC | Eisai | United States | federal | 2007 | $2,265,000 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2004 | $2,255,121 | federal grant | |
| PTC THERAPEUTICS, INC | PTC Therapeutics | United States | federal | 2006 | $2,219,415 | federal grant | |
| PROTEIN SCIENCES CORPORATION | Sanofi | United States | federal | 2003 | $2,213,730 | federal grant | |
| NOVOZYMES, INC | Novo A/S | United States | federal | 2010 | $2,156,352 | federal grant | |
| PROGENICS PHARMACEUTICALS, INC | Progenics Pharmaceuticals | United States | federal | 2001 | $2,090,481 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2004 | $2,040,362 | federal grant | |
| CHIMERIX INC | Chimerix | United States | federal | 2003 | $2,005,821 | federal grant | |
| EASEL BIOTECHNOLOGIES | Celgene | United States | federal | 2015 | $2,000,000 | federal grant | |
| EASEL BIOTECHNOLOGIES | Celgene | United States | federal | 2018 | $2,000,000 | federal grant | |
| PROGENICS PHARMACEUTICALS, INC | Progenics Pharmaceuticals | United States | federal | 2000 | $1,974,283 | federal grant | |
| FLEXION THERAPEUTICS, INC. | Flexion Therapeutics | United States | federal | 2013 | $1,970,121 | federal grant | |
| SANOFI PASTEUR VAXDESIGN CORPORATION | Sanofi | United States | federal | 2015 | $1,923,532 | federal grant | |
| AMERICAN HOME PRODUCTS CORPORATION | Pfizer | United States | federal | 2002 | $1,894,602 | federal grant | |
| CHIRON CORPORATION | Novartis | United States | federal | 2002 | $1,894,091 | federal grant | |
| MORPHOTEK INC | Eisai | United States | federal | 2008 | $1,776,380 | federal grant | |
| NOVARTIS VACCINES AND DIAGNOSTICS, INC | Novartis | United States | federal | 2015 | $1,717,293 | federal grant | |
| SANOFI PASTEUR VAXDESIGN CORPORATION | Sanofi | United States | federal | 2018 | $1,627,483 | federal grant | |
| AMERICAN HOME PRODUCTS CORPORATION | Pfizer | United States | federal | 2003 | $1,616,058 | federal grant | |
| IMMUNOMEDICS, INC. | Immunomedics | United States | federal | 2013 | $1,615,021 | federal grant | |
| REGENERON PHARMACEUTICALS INC | Regeneron Pharmaceuticals | United States | federal | 2010 | $1,595,238 | federal grant | |
| IBIS BIOSCIENCES INC | Abbott Laboratories | United States | federal | 2009 | $1,591,169 | federal grant | |
| ANIMAS CORPORATION | Johnson & Johnson | United States | federal | 2001 | $1,589,000 | federal grant | |
| NOVOZYMES NORTH AMERICA, INC. | Novo A/S | United States | federal | 2017 | $1,568,670 | federal grant | |
| NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, | Novartis | United States | federal | 2018 | $1,546,698 | federal grant | |
| OPTIMER PHARMACEUTICALS INC | Merck | United States | federal | 2005 | $1,521,978 | federal grant | |
| REGENERON PHARMACEUTICALS INC | Regeneron Pharmaceuticals | United States | federal | 2006 | $1,521,300 | federal grant | |
| SANOFI PASTEUR VAXDESIGN CORPORATION | Sanofi | United States | federal | 2017 | $1,500,013 | federal grant | |
| PROTEIN SCIENCES CORPORATION | Sanofi | United States | federal | 2001 | $1,478,925 | federal grant | |
| EMBREX, INC. | Pfizer | United States | federal | 2005 | $1,403,707 | federal grant | |
| CELGENE CORPORATION | Celgene | United States | federal | 2011 | $1,400,000 | federal grant | |
| CHEMOCENTRYX, INC. | ChemoCentryx | United States | federal | 2000 | $1,372,600 | federal grant | |
| ALEXION ANTIBODY TECHNOLOGIES | Alexion Pharmaceuticals | United States | federal | 2005 | $1,356,000 | federal grant |
Download results as or XML
or XML
